HK1037675A1 - Human orphan g protein-coupled receptor rup3. - Google Patents

Human orphan g protein-coupled receptor rup3.

Info

Publication number
HK1037675A1
HK1037675A1 HK01108607A HK01108607A HK1037675A1 HK 1037675 A1 HK1037675 A1 HK 1037675A1 HK 01108607 A HK01108607 A HK 01108607A HK 01108607 A HK01108607 A HK 01108607A HK 1037675 A1 HK1037675 A1 HK 1037675A1
Authority
HK
Hong Kong
Prior art keywords
protein
rup3
coupled receptor
human orphan
orphan
Prior art date
Application number
HK01108607A
Other languages
English (en)
Inventor
Ruoping Chen
Huong T Dang
Chen W Liaw
I-Lin Lin
Original Assignee
Arena Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharm Inc filed Critical Arena Pharm Inc
Publication of HK1037675A1 publication Critical patent/HK1037675A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01108607A 1998-11-20 2001-12-07 Human orphan g protein-coupled receptor rup3. HK1037675A1 (en)

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US10921398P 1998-11-20 1998-11-20
US12041699P 1999-02-16 1999-02-16
US12185299P 1999-02-26 1999-02-26
US12394999P 1999-03-12 1999-03-12
US12394699P 1999-03-12 1999-03-12
US13643799P 1999-05-28 1999-05-28
US13713199P 1999-05-28 1999-05-28
US13712799P 1999-05-28 1999-05-28
US13643999P 1999-05-28 1999-05-28
US13656799P 1999-05-28 1999-05-28
US13643699P 1999-05-28 1999-05-28
US14144899P 1999-06-29 1999-06-29
US15663499P 1999-09-29 1999-09-29
US15663399P 1999-09-29 1999-09-29
US15655599P 1999-09-29 1999-09-29
US15665399P 1999-09-29 1999-09-29
US15729499P 1999-10-01 1999-10-01
US15729399P 1999-10-01 1999-10-01
US15728199P 1999-10-01 1999-10-01
US15728299P 1999-10-01 1999-10-01
US15728099P 1999-10-01 1999-10-01
US41676099A 1999-10-12 1999-10-12
US41704499A 1999-10-12 1999-10-12
PCT/US1999/023687 WO2000031258A2 (en) 1998-11-20 1999-10-13 Human orphan g protein-coupled receptors

Publications (1)

Publication Number Publication Date
HK1037675A1 true HK1037675A1 (en) 2002-02-15

Family

ID=27586698

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01108607A HK1037675A1 (en) 1998-11-20 2001-12-07 Human orphan g protein-coupled receptor rup3.
HK07112367A HK1103763A1 (en) 1998-11-20 2005-12-02 Human orphan g protein-coupled receptor rup3

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07112367A HK1103763A1 (en) 1998-11-20 2005-12-02 Human orphan g protein-coupled receptor rup3

Country Status (13)

Country Link
EP (8) EP1849866B1 (de)
JP (5) JP2003534767A (de)
KR (5) KR100765039B1 (de)
AT (3) ATE396400T1 (de)
AU (2) AU770056B2 (de)
CA (2) CA2645717A1 (de)
DK (3) DK1584683T3 (de)
ES (3) ES2243095T3 (de)
HK (2) HK1037675A1 (de)
IL (2) IL142538A0 (de)
NZ (3) NZ511087A (de)
PT (3) PT1849866E (de)
WO (1) WO2000031258A2 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3276699A (en) 1998-03-12 1999-09-27 Yamanouchi Pharmaceutical Co., Ltd. Novel g protein-coupled receptor proteins
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
WO1999055733A1 (en) * 1998-04-24 1999-11-04 Smithkline Beecham Corporation Cloning of a novel 7tm receptor axor-2
WO2000026339A2 (en) * 1998-11-03 2000-05-11 Smithkline Beecham Corporation Axor14, a g-protein coupled receptor
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
WO2000050458A1 (en) * 1999-02-26 2000-08-31 Smithkline Beecham Corporation Cloning of a p2y-like 7tm receptor (axor17)
US6620615B1 (en) * 1999-04-23 2003-09-16 Curagen Corporation G-protein coupled receptor—encoding nucleic acids
EP1189944A4 (de) * 1999-06-21 2002-09-11 Smithkline Beecham Corp G-protein gekoppelter rezeptor axor16
EP1194551A1 (de) * 1999-07-13 2002-04-10 MERCK PATENT GmbH An ein g-protein gekoppelter rezeptor und dazugehörige dns
CA2381437A1 (en) * 1999-07-30 2001-02-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung G-protein coupled receptor and dna sequences thereof
CA2382889A1 (en) * 1999-08-27 2001-03-08 Takuya Watanabe Novel g protein-coupled receptor protein and dna thereof
US6998255B1 (en) 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
US6204017B1 (en) * 1999-10-07 2001-03-20 Schering Corporation Polynucleotide encoding a histamine receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923893D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9924956D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
CA2386509A1 (en) * 1999-10-27 2001-05-03 Pharmacia & Upjohn Company G protein-coupled receptors expressed in human brain
EP1096009B1 (de) * 1999-10-29 2007-10-10 Pfizer Limited G-protein-gekoppelter rezeptor-ähnliche proteine
JP2003513629A (ja) * 1999-11-03 2003-04-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 新規なｇｐｃｒ＿ｋｄ５ポリペプチドおよびそのｄｎａ配列
US6461836B1 (en) * 1999-11-05 2002-10-08 Smithkline Beecham Corporation Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
US7029857B1 (en) 1999-12-17 2006-04-18 H. Lundbeck A/S Processes for obtaining compounds employing SNORF72 receptors
AU2398501A (en) * 1999-12-20 2001-07-03 Banyu Pharmaceutical Co., Ltd. Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26
WO2001046454A1 (en) 1999-12-23 2001-06-28 Cor Therapeutics, Inc. P2y12 receptor
AU2230401A (en) * 1999-12-28 2001-07-09 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
GB0001700D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Novel protein
WO2001057524A1 (fr) * 2000-02-04 2001-08-09 Takeda Chemical Industries, Ltd. Procede de criblage
AU2001252181A1 (en) * 2000-03-14 2001-09-24 Bayer Aktiengesellschaft Regulation of human lipoxin a4 receptor-like protein
US20040091863A1 (en) * 2000-03-17 2004-05-13 Shyam Ramakrishnan Regulation of human leukotriene b4-like g protein-coupled receptor
EP1270589A4 (de) * 2000-03-21 2004-09-29 Yamanouchi Pharma Co Ltd Neuer leukotrienb4 rezeptor
AU2001242800A1 (en) * 2000-03-28 2001-10-08 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
WO2001073023A1 (fr) * 2000-03-31 2001-10-04 Helix Research Institute Nouveau recepteur gprv53 couple a une proteine se liant a la guanosine-triphosphate, gene correspondant et procede de production et d'utilisation associe
WO2001077326A1 (fr) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Proteine receptrice couplee a la proteine g et son adn
EP1178110A1 (de) * 2000-08-01 2002-02-06 Aventis Pharma Deutschland GmbH EDG8 Rezeptor für Sphingosine 1-Phosphate , dessen Herstellung und Anwendung
DK1287133T3 (da) * 2000-05-18 2007-03-26 Bayer Healthcare Ag Regulering af human dopamin-lignende G-protein-koblet receptor
WO2002000719A2 (en) * 2000-06-23 2002-01-03 Tularik Inc. Human and mouse g-protein couipled receptors
JP2004501629A (ja) * 2000-06-26 2004-01-22 アクゾ・ノベル・エヌ・ベー Ｇタンパク質共役受容体ｏｒｇ１０
AU2001281933A1 (en) * 2000-06-30 2002-01-14 Ingenium Pharmaceuticals Ag Human g protein-coupled receptor igpcr17, and uses therof
WO2002004518A2 (en) * 2000-07-06 2002-01-17 Bayer Corporation Human neuropeptide y-like g protein-coupled receptor
EP1311546A2 (de) * 2000-08-09 2003-05-21 Millenium Pharmaceuticals, Inc. Verfahren zur verwendung des menschlichen g-protein-gekoppelten rezeptors 14266
US6790608B2 (en) * 2000-09-20 2004-09-14 The Regents Of The University Of California Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist
AU2002210982A1 (en) * 2000-11-01 2002-05-15 Yamanouchi Pharmaceutical Co..Ltd. Method of screening antiplatelet
EP1337558B1 (de) * 2000-11-07 2010-09-01 Takeda Pharmaceutical Company Limited Ein "bach" g-protein gekoppelter rezeptor und dafür kodierende polynucleotide
AU1989002A (en) * 2000-11-27 2002-06-03 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
US20030180813A1 (en) 2000-12-01 2003-09-25 Takahide Ohishi Method of screening remedy for diabetes
AU2002245182A1 (en) * 2000-12-22 2002-07-08 Mergen Ltd. Methods for identifying g-protein coupled receptors associated with diseases
US7220580B2 (en) 2000-12-22 2007-05-22 University Of South Florida Sphingosine 1-phosphate receptor gene, sppr
GB0100782D0 (en) * 2001-01-11 2001-02-21 Glaxo Group Ltd Assay
ES2311601T3 (es) * 2001-04-25 2009-02-16 Astellas Pharma Inc. Receptores acoplado a proteina que se une a trifosfato de guanosina place 6002312 y su gen y produccion y uso del mismo.
US7858755B2 (en) 2001-07-09 2010-12-28 Euroscreen S.A. Monoclonal antibodies that bind Chemerin polypeptide
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US7419658B2 (en) 2001-07-09 2008-09-02 Euroscreen S.A. Isolated ligand of ChemerinR
US6946244B2 (en) 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
CN1324047C (zh) 2002-04-12 2007-07-04 先灵公司 G蛋白偶联受体的配体与方法
AU2003261874A1 (en) * 2002-09-02 2004-03-29 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
JPWO2004033687A1 (ja) * 2002-10-11 2006-02-09 アステラス製薬株式会社 腎不全治療薬をスクリーニングする方法
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
JP4516430B2 (ja) 2002-12-20 2010-08-04 メルク・シャープ・エンド・ドーム・コーポレイション １−（アミノ）インダン並びに（１，２−ジヒドロ−３−アミノ）−ベンゾフラン、ベンゾチオフェン及びインドール
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
JP2007526747A (ja) * 2003-06-27 2007-09-20 タノックス インコーポレーテッド ヒトマスト細胞発現膜タンパク質
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
GB0508990D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
DK1971862T3 (da) 2006-04-11 2011-02-14 Arena Pharm Inc Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CN101754962B (zh) 2007-07-19 2013-12-25 赛马拜制药公司 作为rup3或gpr119受体的激动剂治疗糖尿病和代谢性病症的n-氮杂环状经取代吡咯、吡唑、咪唑、***和四唑衍生物
RU2443699C2 (ru) 2007-09-20 2012-02-27 Айрм Ллк Соединения и композиции в качестве модуляторов активности gpr119
EP2108960A1 (de) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
CN102666553B (zh) 2009-10-01 2015-05-06 赛马拜制药公司 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
JP2013523819A (ja) 2010-04-06 2013-06-17 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置
BR112012032248A2 (pt) 2010-06-23 2016-09-13 Metabolex Inc composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
KR101871011B1 (ko) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Ｇｐｒ１１９ 수용체의 조절제 및 그와 관련된 장애의 치료
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
UA126268C2 (uk) 2015-01-06 2022-09-14 Арена Фармасьютікалз, Інк. СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub>
EA201890096A1 (ru) 2015-06-22 2018-08-31 Арена Фармасьютикалз, Инк. КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ
US10292983B2 (en) 2016-08-03 2019-05-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
EP3641887A1 (de) 2017-06-19 2020-04-29 Arena Pharmaceuticals, Inc. Verbindung und verfahren zur behandlung von nafld und nash

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020045A2 (en) * 1995-11-15 1997-06-05 Cor Therapeutics, Inc. P2u2 PURINERGIC RECEPTOR
EP0955808A1 (de) * 1996-01-11 1999-11-17 Human Genome Sciences, Inc. Humaner, in g-protein gekoppelter rezeptor
WO1998031810A2 (en) * 1997-01-21 1998-07-23 Schering Corporation Mammalian chemokines; receptors; reagents; uses
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US5955303A (en) * 1997-03-06 1999-09-21 Incyte Pharmaceuticals, Inc. Human chemokine receptor-like protein
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6060272A (en) * 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
EP0899332A3 (de) * 1997-08-15 2000-07-05 Smithkline Beecham Corporation G-Protein gekoppelter Rezeptor HFIAO41
CA2239255A1 (en) * 1997-10-23 1999-04-23 Smithkline Beecham Corporation Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins
KR100629185B1 (ko) * 1997-11-11 2006-09-28 오노 야꾸힝 고교 가부시키가이샤 인간 리조포스파티드산 수용체 물질 및 그 용도
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
JP2002504492A (ja) * 1998-02-20 2002-02-12 スミスクライン ビーチャム コーポレーション Ｇタンパク質共役型受容体Ｆｉｓｈｂｏｙ
AU3276699A (en) * 1998-03-12 1999-09-27 Yamanouchi Pharmaceutical Co., Ltd. Novel g protein-coupled receptor proteins
WO1999052945A2 (en) * 1998-04-16 1999-10-21 Millenium Pharmaceuticals, Inc. NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
US6071722A (en) * 1998-04-24 2000-06-06 Smithkline Beecham Corporation Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
SE9801455D0 (sv) * 1998-04-24 1998-04-24 Astra Pharma Inc New receptor
WO1999055733A1 (en) * 1998-04-24 1999-11-04 Smithkline Beecham Corporation Cloning of a novel 7tm receptor axor-2
AU5575299A (en) * 1998-08-19 2000-03-14 Millennium Pharmaceuticals, Inc. 14274 receptor, a g-protein coupled receptor related to the edg receptor family
AU5578699A (en) * 1998-08-20 2000-03-14 Millennium Pharmaceuticals, Inc. 14400 receptor, a g-protein coupled receptor
WO2000011015A1 (en) * 1998-08-24 2000-03-02 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
AU5801099A (en) * 1998-09-02 2000-03-21 Millennium Pharmaceuticals, Inc. 14926 receptor, a novel g-protein coupled receptor
NZ510712A (en) * 1998-10-13 2004-11-26 Arena Pharm Inc Non-endogenous, constitutively activated human G protein-coupled receptors
WO2000023588A2 (en) * 1998-10-16 2000-04-27 Millennium Pharmaceuticals, Inc. G-protein coupled receptors
EP1127128A1 (de) * 1998-11-04 2001-08-29 Chiron Corporation Isolierte vshk-1 rezeptor-polypeptide und verfahren zu deren anwendung
ATE342974T1 (de) * 1998-11-06 2006-11-15 Bayer Healthcare Ag G-protein-gekoppelter rezeptoren, die holomog zu ebv-induzierter gpcr (ebi-2) sind, verfahren zur identifizierung von ihren entsprechenden liganden
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6689866B1 (en) * 1999-03-09 2004-02-10 Curagen Corporation Polynucleotides and proteins encoded thereby
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
US6590938B1 (en) * 1999-09-30 2003-07-08 Conexant Systems, Inc. DCT domain conversion of a higher definition signal to lower definition signal

Also Published As

Publication number Publication date
KR20080104062A (ko) 2008-11-28
NZ527622A (en) 2005-03-24
ES2289610T3 (es) 2008-02-01
AU3790400A (en) 2000-06-13
WO2000031258A3 (en) 2000-10-05
NZ537625A (en) 2006-08-31
PT1584683E (pt) 2007-10-17
EP1849866B1 (de) 2008-05-21
KR100926209B1 (ko) 2009-11-09
JP2003534767A (ja) 2003-11-25
JP2004267216A (ja) 2004-09-30
KR100963367B1 (ko) 2010-06-14
KR20080024234A (ko) 2008-03-17
KR20080024233A (ko) 2008-03-17
ES2243095T3 (es) 2005-11-16
CA2645717A1 (en) 2000-06-02
KR100926208B1 (ko) 2009-11-09
IL142538A (en) 2010-11-30
KR20010086040A (ko) 2001-09-07
EP1580271A3 (de) 2006-01-18
EP1849866A2 (de) 2007-10-31
NZ511087A (en) 2004-01-30
AU2004202147A1 (en) 2004-06-10
EP1133559A2 (de) 2001-09-19
CA2348377A1 (en) 2000-06-02
PT1849866E (pt) 2008-08-28
ATE301673T1 (de) 2005-08-15
ATE396400T1 (de) 2008-06-15
JP2008133300A (ja) 2008-06-12
KR20070097564A (ko) 2007-10-04
DK1133559T3 (da) 2006-04-10
ES2308759T3 (es) 2008-12-01
EP1584683A1 (de) 2005-10-12
PT1133559E (pt) 2005-10-31
DK1849866T3 (da) 2008-09-08
HK1103763A1 (en) 2007-12-28
EP1580271A2 (de) 2005-09-28
EP2295574A1 (de) 2011-03-16
CA2348377C (en) 2008-12-02
EP1584683B1 (de) 2007-07-11
EP2295572A1 (de) 2011-03-16
EP1780280A1 (de) 2007-05-02
KR100765039B1 (ko) 2007-10-09
JP2007209352A (ja) 2007-08-23
AU770056B2 (en) 2004-02-12
EP1849866A3 (de) 2007-11-07
EP1133559B1 (de) 2005-08-10
EP2295573A1 (de) 2011-03-16
IL142538A0 (en) 2002-03-10
WO2000031258A2 (en) 2000-06-02
ATE366815T1 (de) 2007-08-15
JP2009298791A (ja) 2009-12-24
DK1584683T3 (da) 2007-10-29

Similar Documents

Publication Publication Date Title
HK1103763A1 (en) Human orphan g protein-coupled receptor rup3
ATE212055T1 (de) Östrogen-rezeptor
HK1066018A1 (en) Soluble t cell receptor.
AUPR833401A0 (en) G protein-coupled receptor antagonists
DE69837606D1 (de) Cystein-reiche rezeptoren-train
WO2001077172A3 (en) Non-endogenous, constitutively activated known g protein-coupled receptors
WO2002068600A3 (en) Endogenous and non-endogenous versions of human g protein-coupled receptors
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
EP1157097A4 (de) DEM GALANINREZEPTOR äHNELNDER G-PROTEIN GEKOPPELTER REZEPTOR
AU2001240097A1 (en) G protein-coupled receptors
WO2000052039A3 (en) Lectomedin materials and methods
EP1142909A4 (de) Guanosintriphosphat (gtp)-bindendes protein-gekoppelter rezeptor
EP1120426A4 (de) G-protein-gekoppelte rezeptoren
CY1107740T1 (el) Ανθρωπινος ορφανος συζευγμενος σε g πρωτεϊνη υποδοχεας rup3
AU2001238682A1 (en) Human g protein-coupled receptors
AU2001255472A1 (en) Novel g protein-coupled receptor con-218
WO2004069859A3 (en) Restoring function to gonadotropin releasing hormone receptor mutants
AU2001259123A1 (en) Novel g protein-coupled receptor
GB0107914D0 (en) 7tm receptor hlwar77
AU2001279232A1 (en) Methods for using 14266, a human g protein-coupled receptor
AU2001241735A1 (en) Novel g protein-coupled receptors
AU2002335414A1 (en) Novel g protein-coupled receptor
GB0107802D0 (en) Novel g-protein coupled receptor
AU2002950373A0 (en) G protein-coupled receptor antagonists
AU2001245514A1 (en) Novel g protein-coupled receptors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151013